A new indole glycoside from the seeds of Raphanus sativus

Arch Pharm Res. 2016 Jun;39(6):755-61. doi: 10.1007/s12272-016-0758-0. Epub 2016 May 19.

Abstract

A new indole glycoside, β-D-glucopyranosyl 2-(methylthio)-1H-indole-3-carboxylate, named raphanuside A (1), as well as eight known compounds, β-D-fructofuranosyl-(2 → 1)-(6-O-sinapoyl)-α-D-glucopyranoside (2), (3-O-sinapoyl)-β-D-fructofuranosyl-(2 → 1)-α-D-glucopyranoside (3), (3-O-sinapoyl)-β-D-fructofuranosyl-(2 → 1)-(6-O-sinapoyl)-α-D-glucopyranoside (4), (3,4-O-disinapoyl)-β-D-fructofuranosyl-(2 → 1)-(6-O-sinapoyl)-α-D-glucopyranoside (5), isorhamnetin 3,4'-di-O-β-D-glucoside (6), isorhamnetin 3-O-β-D-glucoside-7-O-α-L-rhamnoside (7), isorhamnetin 3-O-β-D-glucoside (8) and 3'-O-methyl-(-)-epicatechin 7-O-β-D-glucoside (9) were isolated from the seeds of Raphanus sativus. Furthermore, compounds 1-3 and 6-9, were isolated from this plant for the first time. The structures of compounds 1-9 were identified using 1D and 2D NMR, including (1)H-(1)H COSY, HSQC, HMBC and NOESY spectroscopic analyses. The inhibitory activity of these isolated compounds against interleukin-6 (IL-6) production in TNF-α stimulated MG-63 cells was also examined.

Keywords: Brassicaceae; IL-6 inhibitory effect; Indole glycoside; Raphanus sativus.

MeSH terms

  • Anti-Inflammatory Agents / isolation & purification*
  • Anti-Inflammatory Agents / pharmacology
  • Cell Line, Tumor
  • Drug Discovery / methods*
  • Enzyme-Linked Immunosorbent Assay
  • Glycosides / isolation & purification*
  • Glycosides / pharmacology
  • Humans
  • Indoles / isolation & purification*
  • Indoles / pharmacology
  • Interleukin-6 / biosynthesis*
  • Molecular Structure
  • Raphanus / chemistry*
  • Seeds / chemistry
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Anti-Inflammatory Agents
  • Glycosides
  • Indoles
  • Interleukin-6
  • Tumor Necrosis Factor-alpha